Carcinoid myopathy and treatment with cyproheptadine (Periactin)

22Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

A case of the carcinoid syndrome associated with a proximal myopathy is reported. Histology showed advanced atrophy of type II muscle fibers but no inflammation. Perinuclear acid phosphatase was increased. Electron microscopy revealed persistence of the Z line until the muscle fiber had been severely disrupted. Similar lesions have been observed in the hereditary muscular dystrophy in mice, and also in these animals and in rats when injected with 5 hydroxytryptamine (5 HT). Treatment with cyproheptadine caused a documented response in the patient's debilitating diarrhea and also produced symptomatic improvement in her muscular power. It is suggested that the myopathy is due to circulating 5 HT or is a nonmetastatic complication of the carcinoid tumor.

Cite

CITATION STYLE

APA

Berry, E. M., Maunder, C., & Wilson, M. (1974). Carcinoid myopathy and treatment with cyproheptadine (Periactin). Gut, 15(1), 34–38. https://doi.org/10.1136/gut.15.1.34

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free